Mount Michael G, White Nicholas R, Nguyen Christophe L, Orr Richard K, Hird Robert B
Spartanburg Medical Center, Gibbs Cancer Center and Research Institute, Spartanburg, South Carolina, USA.
Am Surg. 2015 May;81(5):454-7.
Sentinel lymph node biopsy (SLNB) is used to detect axillary lymph node metastases in breast cancer. Preoperative radiocolloid injection with lymphoscintigraphy (PL) is performed before SLNB. Few comparisons between 1- and 2-day PL protocols exist. Opponents of a 2-day protocol have expressed concerns of radiotracer washout to nonsentinel nodes. Proponents cite lack of scheduling conflicts between PL and surgery. A total of 387 consecutive patients with clinically node-negative breast cancer underwent SLNB with PL. Lymphoscintigraphy images were obtained within 30 minutes of radiocolloid injection. Axillary lymph node dissection was performed if the sentinel lymph node (SLN) could not be identified. Data were collected regarding PL technique and results. In all, 212 patients were included in the 2-day PL group and 175 patients in the 1-day PL group. Lymphoscintigraphy identified an axillary sentinel node in 143/212 (67.5%) of patients in the 2-day group and 127/175 (72.5%) in the 1-day group (P = 0.28). SLN was identified at surgery in 209/212 (98.6%) patients in the 2-day group and 174/175 (99.4%) in the 1-day group (P = 0.41). An average of 3 SLN was found at surgery in the 2-day group compared with 3.15 in the 1-day group (P = 0.43). SLN was positive for metastatic disease in 54/212 (25.5%) patients in the 2-day group compared with 40/175 (22.9%) in the 1-day group (P = 0.55). A 2-day lymphoscintigraphy protocol allows reliable detection of the SLN, of positive SLN and equivalent SLN harvest compared with a 1-day protocol. The timing of radiocolloid injection before SLNB can be left at the discretion of the surgeon.
前哨淋巴结活检(SLNB)用于检测乳腺癌腋窝淋巴结转移。在进行SLNB之前先进行术前放射性胶体注射联合淋巴闪烁显像(PL)。关于1天和2天PL方案的比较很少。2天方案的反对者对放射性示踪剂洗脱至非前哨淋巴结表示担忧。支持者则指出PL与手术之间不存在时间安排冲突。共有387例连续的临床腋窝淋巴结阴性乳腺癌患者接受了PL联合SLNB。在放射性胶体注射后30分钟内获取淋巴闪烁显像图像。如果无法识别前哨淋巴结(SLN),则进行腋窝淋巴结清扫。收集有关PL技术和结果的数据。2天PL组共纳入212例患者,1天PL组纳入175例患者。淋巴闪烁显像在2天组143/212例(67.5%)患者中识别出腋窝前哨淋巴结,在1天组127/175例(72.5%)患者中识别出腋窝前哨淋巴结(P = 0.28)。2天组209/212例(98.6%)患者在手术中识别出SLN,1天组174/175例(99.4%)患者在手术中识别出SLN(P = 0.41)。2天组手术中平均发现3个SLN,1天组为3.15个(P = 0.43)。2天组54/212例(25.5%)患者的SLN存在转移灶,1天组40/175例(22.9%)患者的SLN存在转移灶(P = 0.55)。与1天方案相比,2天淋巴闪烁显像方案能够可靠地检测SLN、阳性SLN并获得相当的SLN切除数量。SLNB前放射性胶体注射的时间可由外科医生自行决定。